drugset
drugset / Trial / NCT01360944

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

NCT01360944 ↗

Phase 2 Completed 22 enrolled Almirall, S.A. Sciderm GmbH · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the exploratory study is to compare the dose-related efficacy of LAS41004 in a Psoriasis Plaque Test (PPT).

Timeline

Start
2011-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject LAS41004 Unknown 100 ug Topical

Indications

psoriasis